Katherine N Bachmann1, Melanie Schorr1, Alexander G Bruno2,3, Miriam A Bredella4, Elizabeth A Lawson1, Corey M Gill5, Vibha Singhal1,6, Erinne Meenaghan7, Anu V Gerweck7, Meghan Slattery7, Kamryn T Eddy8, Seda Ebrahimi9, Stuart L Koman10, James M Greenblatt10, Robert J Keane10, Thomas Weigel11, Madhusmita Misra1,6, Mary L Bouxsein2,3, Anne Klibanski1, Karen K Miller1. 1. Neuroendocrine Unit. 2. Harvard-Massachusetts Institute of Technology Health Sciences and Technology Program, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139. 3. Center for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Massachusetts, 02215. 4. Department of Radiology. 5. Department of Radiology and. 6. Pediatric Endocrine Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, 02114. 7. Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, 02114. 8. Department of Psychiatry, and. 9. Cambridge Eating Disorders Center, Cambridge, Massachusetts, 02138. 10. Walden Behavioral Care, Waltham, Massachusetts, 02453. 11. Klarman Center, McLean Hospital, and Harvard Medical School, Belmont, Massachusetts, 02478; and.
Abstract
Context: Areal bone mineral density (BMD) is lower, particularly at the spine, in low-weight women with anorexia nervosa (AN). However, little is known about vertebral integral volumetric BMD (Int.vBMD) or vertebral strength across the AN weight spectrum, including "atypical" AN [body mass index (BMI) ≥18.5 kg/m2]. Objective: To investigate Int.vBMD and vertebral strength, and their determinants, across the AN weight spectrum. Design: Cross-sectional observational study. Setting: Clinical research center. Participants: 153 women (age 18 to 45): 64 with low-weight AN (BMI <18.5 kg/m2; 58% amenorrheic), 44 with atypical AN (18.5≤BMI<23 kg/m2; 30% amenorrheic), 45 eumenorrheic controls (19.2≤BMI<25 kg/m2). Measures: Int.vBMD and cross-sectional area (CSA) by quantitative computed tomography of L4; estimated vertebral strength (derived from Int.vBMD and CSA). Results: Int.vBMD and estimated vertebral strength were lowest in low-weight AN, intermediate in atypical AN, and highest in controls. CSA did not differ between groups; thus, vertebral strength (calculated using Int.vBMD and CSA) was driven by Int.vBMD. In AN, Int.vBMD and vertebral strength were associated positively with current BMI and nadir lifetime BMI (independent of current BMI). Int.vBMD and vertebral strength were lower in AN with current amenorrhea and longer lifetime amenorrhea duration. Among amenorrheic AN, Int.vBMD and vertebral strength were associated positively with testosterone. Conclusions: Int.vBMD and estimated vertebral strength (driven by Int.vBMD) are impaired across the AN weight spectrum and are associated with low BMI and endocrine dysfunction, both current and previous. Women with atypical AN experience diminished vertebral strength, partially due to prior low-weight and/or amenorrhea. Lack of current low-weight or amenorrhea in atypical AN does not preclude compromise of vertebral strength.
Context: Areal bone mineral density (BMD) is lower, particularly at the spine, in low-weight women with anorexia nervosa (AN). However, little is known about vertebral integral volumetric BMD (Int.vBMD) or vertebral strength across the AN weight spectrum, including "atypical" AN [body mass index (BMI) ≥18.5 kg/m2]. Objective: To investigate Int.vBMD and vertebral strength, and their determinants, across the AN weight spectrum. Design: Cross-sectional observational study. Setting: Clinical research center. Participants: 153 women (age 18 to 45): 64 with low-weight AN (BMI <18.5 kg/m2; 58% amenorrheic), 44 with atypical AN (18.5≤BMI<23 kg/m2; 30% amenorrheic), 45 eumenorrheic controls (19.2≤BMI<25 kg/m2). Measures: Int.vBMD and cross-sectional area (CSA) by quantitative computed tomography of L4; estimated vertebral strength (derived from Int.vBMD and CSA). Results: Int.vBMD and estimated vertebral strength were lowest in low-weight AN, intermediate in atypical AN, and highest in controls. CSA did not differ between groups; thus, vertebral strength (calculated using Int.vBMD and CSA) was driven by Int.vBMD. In AN, Int.vBMD and vertebral strength were associated positively with current BMI and nadir lifetime BMI (independent of current BMI). Int.vBMD and vertebral strength were lower in AN with current amenorrhea and longer lifetime amenorrhea duration. Among amenorrheic AN, Int.vBMD and vertebral strength were associated positively with testosterone. Conclusions: Int.vBMD and estimated vertebral strength (driven by Int.vBMD) are impaired across the AN weight spectrum and are associated with low BMI and endocrine dysfunction, both current and previous. Women with atypical AN experience diminished vertebral strength, partially due to prior low-weight and/or amenorrhea. Lack of current low-weight or amenorrhea in atypical AN does not preclude compromise of vertebral strength.
Authors: Alexander G Bruno; Kerry E Broe; Xiaochun Zhang; Elizabeth J Samelson; Ching-An Meng; Rajaram Manoharan; John D'Agostino; L Adrienne Cupples; Douglas P Kiel; Mary L Bouxsein Journal: J Bone Miner Res Date: 2014-03 Impact factor: 6.741
Authors: Serra Ucer; Srividhya Iyer; Shoshana M Bartell; Marta Martin-Millan; Li Han; Ha-Neui Kim; Robert S Weinstein; Robert L Jilka; Charles A O'Brien; Maria Almeida; Stavros C Manolagas Journal: J Bone Miner Res Date: 2015-07 Impact factor: 6.741
Authors: K K Miller; S Grinspoon; S Gleysteen; K A Grieco; J Ciampa; J Breu; D B Herzog; A Klibanski Journal: J Clin Endocrinol Metab Date: 2004-09 Impact factor: 5.958
Authors: Jennifer Dominguez; Linnea Goodman; Surupa Sen Gupta; Laurel Mayer; Sarah Fischer Etu; B Timothy Walsh; Jack Wang; Richard Pierson; Michelle P Warren Journal: Am J Clin Nutr Date: 2007-07 Impact factor: 7.045
Authors: Melanie Schorr; Anne Drabkin; Micol S Rothman; Erinne Meenaghan; Gillian T Lashen; Margherita Mascolo; Ashlie Watters; Tara M Holmes; Kate Santoso; Elaine W Yu; Madhusmita Misra; Kamryn T Eddy; Anne Klibanski; Philip Mehler; Karen K Miller Journal: Clin Endocrinol (Oxf) Date: 2019-04-01 Impact factor: 3.478
Authors: Laura E Dichtel; Elizabeth A Lawson; Melanie Schorr; Erinne Meenaghan; Margaret Lederfine Paskal; Kamryn T Eddy; Graziano Pinna; Marianela Nelson; Ann M Rasmusson; Anne Klibanski; Karen K Miller Journal: Neuropsychopharmacology Date: 2017-11-01 Impact factor: 7.853
Authors: Angelique F Ralph; Leah Brennan; Sue Byrne; Belinda Caldwell; Jo Farmer; Laura M Hart; Gabriella A Heruc; Sarah Maguire; Milan K Piya; Julia Quin; Sarah K Trobe; Andrew Wallis; A J Williams-Tchen; Phillipa Hay Journal: J Eat Disord Date: 2022-08-18
Authors: Melanie Schorr Haines; Allison Kimball; Erinne Meenaghan; Katherine N Bachmann; Kate Santoso; Kamryn T Eddy; Vibha Singhal; Seda Ebrahimi; Esther Dechant; Thomas Weigel; Lori Ciotti; Robert J Keane; Suzanne Gleysteen; Diane Mickley; Miriam A Bredella; Can Ozan Tan; Rajiv Gupta; Madhusmita Misra; David Schoenfeld; Anne Klibanski; Karen K Miller Journal: J Bone Miner Res Date: 2021-09-02 Impact factor: 6.741